Brittany Irvine

972 total citations
12 papers, 693 citations indexed

About

Brittany Irvine is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Brittany Irvine has authored 12 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Brittany Irvine's work include Hematological disorders and diagnostics (2 papers), Cleft Lip and Palate Research (2 papers) and Blood disorders and treatments (2 papers). Brittany Irvine is often cited by papers focused on Hematological disorders and diagnostics (2 papers), Cleft Lip and Palate Research (2 papers) and Blood disorders and treatments (2 papers). Brittany Irvine collaborates with scholars based in Canada, United States and France. Brittany Irvine's co-authors include James Gomes, Mona Hersi, Pallavi Gupta, Daniel Krewski, Nicholas Birkett, Wei Luo, Ashley A. Basiorka, Alan F. List, Kathy L. McGraw and Thomas Cluzeau and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncotarget.

In The Last Decade

Brittany Irvine

10 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brittany Irvine Canada 8 189 175 159 108 88 12 693
Cathy Zhao Australia 20 118 0.6× 114 0.7× 182 1.1× 80 0.7× 70 0.8× 46 1.1k
A.J. Lehman Canada 12 225 1.2× 114 0.7× 212 1.3× 48 0.4× 81 0.9× 30 1.2k
Mark S. Currie United States 13 158 0.8× 162 0.9× 187 1.2× 133 1.2× 61 0.7× 16 887
Alberto Batticciotto Italy 22 209 1.1× 82 0.5× 385 2.4× 94 0.9× 71 0.8× 66 1.3k
L. Färber Germany 19 96 0.5× 111 0.6× 174 1.1× 106 1.0× 93 1.1× 44 889
Samuela Carraro Italy 11 56 0.3× 106 0.6× 97 0.6× 189 1.8× 212 2.4× 31 678
Chao‐Ping Yang Taiwan 19 268 1.4× 322 1.8× 68 0.4× 56 0.5× 79 0.9× 66 947
Curtis L. Petersen United States 14 160 0.8× 236 1.3× 44 0.3× 156 1.4× 40 0.5× 55 868
Wataru Yamamoto Japan 20 308 1.6× 230 1.3× 193 1.2× 225 2.1× 355 4.0× 119 1.6k
Laura M. Raffield United States 20 56 0.3× 277 1.6× 58 0.4× 150 1.4× 36 0.4× 79 1.1k

Countries citing papers authored by Brittany Irvine

Since Specialization
Citations

This map shows the geographic impact of Brittany Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brittany Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brittany Irvine more than expected).

Fields of papers citing papers by Brittany Irvine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brittany Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brittany Irvine. The network helps show where Brittany Irvine may publish in the future.

Co-authorship network of co-authors of Brittany Irvine

This figure shows the co-authorship network connecting the top 25 collaborators of Brittany Irvine. A scholar is included among the top collaborators of Brittany Irvine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brittany Irvine. Brittany Irvine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hersi, Mona, Brittany Irvine, Pallavi Gupta, et al.. (2017). Risk factors associated with the onset and progression of Alzheimer’s disease: A systematic review of the evidence. NeuroToxicology. 61. 143–187. 226 indexed citations
2.
Cluzeau, Thomas, Kathy L. McGraw, Brittany Irvine, et al.. (2017). Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes. Haematologica. 102(12). 2015–2020. 32 indexed citations
3.
Skinner, Robin, et al.. (2017). Aperçu - Une analyse contextuelle des indicateurs de surveillance du suicide. SHILAP Revista de lepidopterología. 37(8). 281–284.
4.
Skinner, Robin, et al.. (2017). At-a-glance - A contextual analysis of the Suicide Surveillance Indicators. Health Promotion and Chronic Disease Prevention in Canada. 37(8). 257–260. 12 indexed citations
5.
Basiorka, Ashley A., Kathy L. McGraw, David A. Sallman, et al.. (2016). NLRP3 Inflammasome-Derived ASC Specks Are a Diagnostic Biomarker for Myelodysplastic Syndromes (MDS). Blood. 128(22). 2005–2005.
6.
Basiorka, Ashley A., Kathy L. McGraw, Erika A. Eksioglu, et al.. (2016). The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype. Blood. 128(25). 2960–2975. 266 indexed citations
7.
Irvine, Brittany, et al.. (2015). Report Summary - Perinatal Health Indicators 2013: a Surveillance Report by the Public Health Agency of Canada’s Perinatal Surveillance System. Health Promotion and Chronic Disease Prevention in Canada. 35(1). 23–24. 24 indexed citations
8.
Irvine, Brittany, et al.. (2015). Report Summary - Congenital Anomalies in Canada 2013: A Perinatal Health Surveillance Report by the Public Health Agency of Canada’s Canadian Perinatal Surveillance System. Health Promotion and Chronic Disease Prevention in Canada. 35(1). 21–22. 54 indexed citations
9.
McGraw, Kathy L., Thomas Cluzeau, David A. Sallman, et al.. (2015). TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes. Oncotarget. 6(33). 34437–34445. 14 indexed citations
10.
Cluzeau, Thomas, Kathy L. McGraw, Brittany Irvine, et al.. (2015). The Proinflammatory Protein S100A9 Suppresses Erythropoietin Elaboration in Patients with Myelodysplastic Syndromes. Blood. 126(23). 355–355. 2 indexed citations
11.
12.
Olivotto, Ivo A., Christina Bancej, Vivek Goel, et al.. (2001). Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces.. PubMed. 165(3). 277–83. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathy Zhao Breakdown of academic impact, for papers by A.J. Lehman Breakdown of academic impact, for papers by Mark S. Currie Breakdown of academic impact, for papers by Alberto Batticciotto Breakdown of academic impact, for papers by L. Färber Breakdown of academic impact, for papers by Samuela Carraro Breakdown of academic impact, for papers by Chao‐Ping Yang Breakdown of academic impact, for papers by Curtis L. Petersen Breakdown of academic impact, for papers by Wataru Yamamoto Breakdown of academic impact, for papers by Laura M. Raffield
Rankless by CCL
2026